SlideShare a Scribd company logo
Continuous Medical Education Department of Neurosurgery, HKL 14 February 2007 The Pathophysiology and  Management of Hemorrhagic Stroke
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPIDEMIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PATHOPHYSIOLOGY ,[object Object],[object Object],[object Object],[object Object]
PATHOPHYSIOLOGY ,[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object],Guidelines for the Management of Spontaneous Intracerebral Hemorrhage  (1999 American Heart Association )
[object Object],Management Guidelines for the Management of Spontaneous Intracerebral Hemorrhage  (1999 American Heart Association )
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Titrate from 0.05–0.2 µg · kg -1  · min -1 Norepinephrine 2–20 µg · kg -1  · min -1 Dopamine 2–10 µg · kg -1  · min -1 Phenylephrine Volume replenishment is the first line of approach. Isotonic saline or colloids can be used and monitored with central venous pressure or pulmonary artery wedge pressure. If hypotension persists after correction of volume deficit, continuous infusions of pressors should be considered, particularly for low systolic blood pressure such as <90 mm Hg.  Low blood pressure   4. If ICP monitoring is available, cerebral perfusion pressure should be kept at >70 mm Hg.  3. If  systolic  BP is <180 mm Hg and  diastolic  BP <105 mm Hg, defer antihypertensive therapy. Choice of medication depends on other medical contraindications (eg, avoid labetalol in patients with asthma).  2. If  systolic  BP is 180 to 230 mm Hg,  diastolic  BP 105 to 140 mm Hg, or mean arterial BP  130 mm Hg on 2 readings 20 minutes apart, institute intravenous labetalol, esmolol, enalapril, or other smaller doses of easily titratable intravenous medications such as diltiazem, lisinopril, or verapamil.  1. If  systolic  BP is >230 mm Hg or  diastolic  BP >140 mm Hg on 2 readings 5 minutes apart, institute nitroprusside.   0.625–1.2 mg Q 6 h as needed Enalapril 10–20 mg Q 4–6 h Hydralazine 0.5–10 µg · kg -1  · min -1 Nitroprusside 500 µg/kg as a load; maintenance use, 50–200 µg · kg -1  · min -1 Esmolol 5–100 mg/h by intermittent bolus doses of 10–40 mg or continuous drip (2–8 mg/min) Labetalol Elevated blood pressure
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object]
Emergency ICP therapy ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management of ICP   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management   of ICP   ,[object Object],[object Object]
Management of ICP   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management of ICP   ,[object Object],[object Object],[object Object],[object Object]
Management of ICP   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reversal of coagulation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object]
Surgical Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomized trial Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH; STICH investigators. Lancet 2005;365:387–97.
Management  - Treatment ,[object Object],[object Object]
Management  - Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Criteria for surgery ,[object Object],[object Object],[object Object],[object Object],[object Object]
Age ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hematoma Volume ,[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768 71% 60% 7% Lobar 93% 64% 23% Deep >60cm3 30-60cm3 <30cm3 Mortality
Hematoma Volume ,[object Object],[object Object],[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Progression ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Fulminant =  comatose, obtunded, herniation signs   Slowly progressive = lethargy at 6 hours
Timing of Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Timing of Surgery ,[object Object]
Timing of Surgery ,[object Object],[object Object],[object Object],[object Object],2 Neurosurg Focus 15 (4):Article 2, 2003, Update on management of intracerebral hemorrhage, NADER POURATIAN, M.D., PH.D., NEAL F. KASSELL, M.D., AND AARON S. DUMONT, M.D.
Timing of Surgery ,[object Object],[object Object],[object Object],[object Object],2 Neurosurg Focus 15 (4):Article 2, 2003, Update on management of intracerebral hemorrhage, NADER POURATIAN, M.D., PH.D., NEAL F. KASSELL, M.D., AND AARON S. DUMONT, M.D.
Patient’s selection ,[object Object],[object Object],[object Object],2 Neurosurg Focus 15 (4):Article 2, 2003, Update on management of intracerebral hemorrhage, NADER POURATIAN, M.D., PH.D., NEAL F. KASSELL, M.D., AND AARON S. DUMONT, M.D. 4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D
Patient’s selection ,[object Object],[object Object],[object Object],[object Object],4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D
Summary of Guidelines for Removal of ICH American Heart Association :  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage, 1998 Best therapy unclear Young patients with a moderate or large lobar hemorrhage who are clinically deteriorating (levels of evidence II through V, grade B recommendation). 3. ICH associated with a structural lesion such as an aneurysm, arteriovenous malformation, or cavernous angioma may be removed if the patient has a chance for a good outcome and the structural vascular lesion is surgically accessible (levels of evidence III through V, grade C recommendation). 2. Patients with cerebellar hemorrhage >3 cm who are neurologically deteriorating or who have brain stem compression and hydrocephalus from ventricular obstruction should have surgical removal of the hemorrhage as soon as possible (levels of evidence III through V, grade C recommendation). 1. Surgical candidates Patients with a GCS score   4 (levels of evidence II through V, grade B recommendation). However, patients with a GCS score   4 who have a cerebellar hemorrhage with brain stem compression may still be candidates for lifesaving surgery in certain clinical situations. 2. Patients with small hemorrhages (<10 cm 3 ) or minimal neurological deficits (levels of evidence II through V, grade B recommendation). 1. Nonsurgical candidates
Surgical Techniques ,[object Object],[object Object],[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Surgical Techniques ,[object Object],[object Object],[object Object],4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D.
Craniotomy   ,[object Object],[object Object],[object Object],[object Object]
Craniotomy ,[object Object],[object Object],[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Craniotomy ,[object Object],[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Burr Hole Aspiration ,[object Object],[object Object],[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Stereotactic Aspiration ,[object Object],[object Object],[object Object]
Stereotactic Aspiration and Clot Lysis   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Stereotactic Aspiration and Clot Lysis ,[object Object],[object Object],[object Object],[object Object],4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D
Stereotactic Aspiration and Clot Lysis ,[object Object],[object Object]
Neuroendoscpic Techniques ,[object Object],[object Object],[object Object],10 Youmans Neurological Surgery Fifth Edition Volume 2 : Chapter 105 pages 1733-1768
Neuroendoscpic Techniques ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Odds Ratio of Death and Dependency: 0.46  (0.20-1.04) surgery better 74% 58% Poor Outcome 70% 42% Mortality Medical Surgical
Ventriculostomy ,[object Object],[object Object],[object Object]
Surgical Evacuation of Cerebellar ICH ,[object Object],[object Object],[object Object],4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D.
Surgical Evacuation of Cerebellar ICH   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary of Surgical Treatment Recommendations 4 ,[object Object],[object Object],[object Object],[object Object],[object Object],4 Neurosurg Focus 15 (4):Article 1, 2003, Spontaneous intracerebral hemorrhage: a review MATTHEW E. FEWEL, M.D., B. GREGORY THOMPSON, JR., M.D., AND JULIAN T. HOFF, M.D.
ICH Evaluation and Treatment
FUTURE DIRECTIONS ,[object Object],[object Object],[object Object],[object Object]
FUTURE DIRECTIONS -Stem cell therapy  ,[object Object],[object Object],[object Object]
Hemostatic Therapy: Future?  ,[object Object],[object Object],[object Object]
Supported by Levels III through V evidence Grade C Supported by Level II evidence Grade B Supported by Level I evidence Grade A Strength of recommendation Data from anecdotal case series Level V Data from nonrandomized cohort studies using historical controls Level IV Data from nonrandomized concurrent cohort studies Level III Data from randomized trials with high false-positive (   ) or high false-negative (ß) errors Level II Data from randomized trials with low false-positive (   ) and low false-negative (ß) errors Level I Level of evidence
Thank You

More Related Content

What's hot

Raised intra cranial pressure
Raised intra cranial pressureRaised intra cranial pressure
Raised intra cranial pressure
Praveen Nagula
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
Chandan N
 
Hypertensive Crisis
Hypertensive CrisisHypertensive Crisis
Hypertensive Crisis
meducationdotnet
 
Traumatic head injury
Traumatic head injuryTraumatic head injury
Traumatic head injury
NeurologyKota
 
Paraplegia
ParaplegiaParaplegia
Paraplegia
Abino David
 
Hyponatremia
HyponatremiaHyponatremia
Hyponatremia
Doha Rasheedy
 
Subarachnoid hemorrhage
Subarachnoid hemorrhageSubarachnoid hemorrhage
Subarachnoid hemorrhage
airwave12
 
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And ManagementHepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Santosh Narayankar
 
Cerebral venous thrombosis- Treatment
Cerebral venous thrombosis- TreatmentCerebral venous thrombosis- Treatment
Cerebral venous thrombosis- Treatment
Roopchand Ps
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
BALASUBRAMANIAM IYER
 
Stroke
StrokeStroke
Epidural haematoma extradural haemorrhage
Epidural haematoma extradural haemorrhageEpidural haematoma extradural haemorrhage
Epidural haematoma extradural haemorrhage
Karan Rawat
 
Management of head injury
Management of head injuryManagement of head injury
Management of head injury
George Owusu
 
Hypertensive Crisis.ppt
Hypertensive Crisis.pptHypertensive Crisis.ppt
Hypertensive Crisis.ppt
Jwan AlSofi
 
Cardiorenal Syndrome
Cardiorenal SyndromeCardiorenal Syndrome
Cardiorenal Syndrome
Sujay Iyer
 
Head injury
Head injuryHead injury
Head injury
Dr Himanshu Soni
 
Haemorrhagic stroke
Haemorrhagic strokeHaemorrhagic stroke
Haemorrhagic stroke
Bhupendra Shah
 
Intracerebral hemorrhage
Intracerebral hemorrhageIntracerebral hemorrhage
Intracerebral hemorrhage
Neonate Neonatorum
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)
Mohit Aggarwal
 
Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
Dr. Tushar Patil
 

What's hot (20)

Raised intra cranial pressure
Raised intra cranial pressureRaised intra cranial pressure
Raised intra cranial pressure
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Hypertensive Crisis
Hypertensive CrisisHypertensive Crisis
Hypertensive Crisis
 
Traumatic head injury
Traumatic head injuryTraumatic head injury
Traumatic head injury
 
Paraplegia
ParaplegiaParaplegia
Paraplegia
 
Hyponatremia
HyponatremiaHyponatremia
Hyponatremia
 
Subarachnoid hemorrhage
Subarachnoid hemorrhageSubarachnoid hemorrhage
Subarachnoid hemorrhage
 
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And ManagementHepatic Encephalopathy -Pathophysiology,Evaluation And Management
Hepatic Encephalopathy -Pathophysiology,Evaluation And Management
 
Cerebral venous thrombosis- Treatment
Cerebral venous thrombosis- TreatmentCerebral venous thrombosis- Treatment
Cerebral venous thrombosis- Treatment
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Stroke
StrokeStroke
Stroke
 
Epidural haematoma extradural haemorrhage
Epidural haematoma extradural haemorrhageEpidural haematoma extradural haemorrhage
Epidural haematoma extradural haemorrhage
 
Management of head injury
Management of head injuryManagement of head injury
Management of head injury
 
Hypertensive Crisis.ppt
Hypertensive Crisis.pptHypertensive Crisis.ppt
Hypertensive Crisis.ppt
 
Cardiorenal Syndrome
Cardiorenal SyndromeCardiorenal Syndrome
Cardiorenal Syndrome
 
Head injury
Head injuryHead injury
Head injury
 
Haemorrhagic stroke
Haemorrhagic strokeHaemorrhagic stroke
Haemorrhagic stroke
 
Intracerebral hemorrhage
Intracerebral hemorrhageIntracerebral hemorrhage
Intracerebral hemorrhage
 
Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)Approach to a patient with hyponatremia (2) (1)
Approach to a patient with hyponatremia (2) (1)
 
Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
 

Viewers also liked

Student-Directed Learning Notes
Student-Directed Learning NotesStudent-Directed Learning Notes
Student-Directed Learning Notes
ChrissyYCDSB
 
Candela mazzelani google
Candela mazzelani googleCandela mazzelani google
Candela mazzelani google
SJustina
 
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARKSPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
Tsuyoshi Horigome
 
Cardiovascular Medicine (French) Symposia
Cardiovascular Medicine (French) SymposiaCardiovascular Medicine (French) Symposia
Cardiovascular Medicine (French) Symposia
The CRUDEM Foundation
 
Population Growth
Population GrowthPopulation Growth
Population Growth
jacksonthree
 
Hipertension secundaria
Hipertension secundariaHipertension secundaria
Hipertension secundaria
Marcelo Abraham
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
drblack8
 
Atrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/TeleAtrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/Tele
TeleClinEd
 
Asma E Dpoc
Asma E DpocAsma E Dpoc
Asma E Dpoc
galegoo
 
History of scouting
History of scoutingHistory of scouting
History of scouting
Phoenix Troop 109
 
Membrana Hialina
Membrana HialinaMembrana Hialina
Membrana Hialina
VICTOR DE PAZ
 
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARKSPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
Tsuyoshi Horigome
 
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARKSPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
Tsuyoshi Horigome
 
Convulsiones en pediatría
Convulsiones en pediatríaConvulsiones en pediatría
Convulsiones en pediatría
Hospital Guadix
 
01 Simulado de Direito Civil 1/1
01 Simulado de Direito Civil 1/101 Simulado de Direito Civil 1/1
01 Simulado de Direito Civil 1/1
Clairton Rocha
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
Sherry Knowles
 
New Presentation of DP, Korean lang
New Presentation of DP, Korean langNew Presentation of DP, Korean lang
New Presentation of DP, Korean lang
Bengt & Maarit de Paulis
 
Human Nutrition
Human NutritionHuman Nutrition
Human Nutrition
I Wonder Why Science
 
Presentacion general
Presentacion generalPresentacion general
Presentacion general
unefm
 
Presentacion teoremas thevenin
Presentacion teoremas theveninPresentacion teoremas thevenin
Presentacion teoremas thevenin
e_garino
 

Viewers also liked (20)

Student-Directed Learning Notes
Student-Directed Learning NotesStudent-Directed Learning Notes
Student-Directed Learning Notes
 
Candela mazzelani google
Candela mazzelani googleCandela mazzelani google
Candela mazzelani google
 
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARKSPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SK2740 (Standard+BDS Model) in SPICE PARK
 
Cardiovascular Medicine (French) Symposia
Cardiovascular Medicine (French) SymposiaCardiovascular Medicine (French) Symposia
Cardiovascular Medicine (French) Symposia
 
Population Growth
Population GrowthPopulation Growth
Population Growth
 
Hipertension secundaria
Hipertension secundariaHipertension secundaria
Hipertension secundaria
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
 
Atrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/TeleAtrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/Tele
 
Asma E Dpoc
Asma E DpocAsma E Dpoc
Asma E Dpoc
 
History of scouting
History of scoutingHistory of scouting
History of scouting
 
Membrana Hialina
Membrana HialinaMembrana Hialina
Membrana Hialina
 
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARKSPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
SPICE MODEL of 2SJ438 (Standard+BDS Model) in SPICE PARK
 
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARKSPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
SPICE MODEL of 2SK3872-01L (Professional+BDP Model) in SPICE PARK
 
Convulsiones en pediatría
Convulsiones en pediatríaConvulsiones en pediatría
Convulsiones en pediatría
 
01 Simulado de Direito Civil 1/1
01 Simulado de Direito Civil 1/101 Simulado de Direito Civil 1/1
01 Simulado de Direito Civil 1/1
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
 
New Presentation of DP, Korean lang
New Presentation of DP, Korean langNew Presentation of DP, Korean lang
New Presentation of DP, Korean lang
 
Human Nutrition
Human NutritionHuman Nutrition
Human Nutrition
 
Presentacion general
Presentacion generalPresentacion general
Presentacion general
 
Presentacion teoremas thevenin
Presentacion teoremas theveninPresentacion teoremas thevenin
Presentacion teoremas thevenin
 

Similar to The Pathophysiology And Management Of Hemorrhagic Stroke

Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
oday abdow
 
Management of cerebral hemorrhage...A quick guide
Management of cerebral hemorrhage...A quick guideManagement of cerebral hemorrhage...A quick guide
Management of cerebral hemorrhage...A quick guide
Professor Yasser Metwally
 
Hemorragia cerebral.
Hemorragia cerebral.Hemorragia cerebral.
Hemorragia cerebral.
Mi rincón de Medicina
 
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
College of Medicine, Sulaymaniyah
 
Ischaemic stroke cme
Ischaemic stroke cmeIschaemic stroke cme
Ischaemic stroke cme
Siti Aishah Mohd Zameri
 
Stroke
StrokeStroke
Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]
Deepanshu Khanna
 
Update in managment of cva
Update in managment of cvaUpdate in managment of cva
Update in managment of cva
Haifa Alshwikh
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
Myiesha Taylor
 
Seminar on haemorrhage
Seminar on haemorrhageSeminar on haemorrhage
Seminar on haemorrhage
Simran Dhiman
 
Hypertension
HypertensionHypertension
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
saikrishna361975
 
Heart failure imrose
Heart failure imroseHeart failure imrose
Heart failure imrose
Nizam Uddin
 
Ischaemic stroke
Ischaemic stroke Ischaemic stroke
Ischaemic stroke
Osama Ragab
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesia
DrManoj Tripathi
 
Aneurysm
AneurysmAneurysm
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
Ankur Jain
 
Hypertension
HypertensionHypertension
Hypertension
samirelansary
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergencies
sazzad92
 
Post operative management
Post operative management Post operative management
Post operative management
Tapish Sahu
 

Similar to The Pathophysiology And Management Of Hemorrhagic Stroke (20)

Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Management of cerebral hemorrhage...A quick guide
Management of cerebral hemorrhage...A quick guideManagement of cerebral hemorrhage...A quick guide
Management of cerebral hemorrhage...A quick guide
 
Hemorragia cerebral.
Hemorragia cerebral.Hemorragia cerebral.
Hemorragia cerebral.
 
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
Medicine 5th year, 3rd lecture (Dr. Mohammed Tahir)
 
Ischaemic stroke cme
Ischaemic stroke cmeIschaemic stroke cme
Ischaemic stroke cme
 
Stroke
StrokeStroke
Stroke
 
Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]Management of acute ischemic stroke including tia [autosaved]
Management of acute ischemic stroke including tia [autosaved]
 
Update in managment of cva
Update in managment of cvaUpdate in managment of cva
Update in managment of cva
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Seminar on haemorrhage
Seminar on haemorrhageSeminar on haemorrhage
Seminar on haemorrhage
 
Hypertension
HypertensionHypertension
Hypertension
 
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
3.12.23 HTN EMERGENCIES and TREATMENT SCENARIOS
 
Heart failure imrose
Heart failure imroseHeart failure imrose
Heart failure imrose
 
Ischaemic stroke
Ischaemic stroke Ischaemic stroke
Ischaemic stroke
 
Intracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesiaIntracranial aneurysm surgery and anesthesia
Intracranial aneurysm surgery and anesthesia
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
Stroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.pptStroke-and-Spinal-Cord-7-30.ppt
Stroke-and-Spinal-Cord-7-30.ppt
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and EmergenciesHypertensive Encephalopathy and Emergencies
Hypertensive Encephalopathy and Emergencies
 
Post operative management
Post operative management Post operative management
Post operative management
 

Recently uploaded

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 

Recently uploaded (20)

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 

The Pathophysiology And Management Of Hemorrhagic Stroke

  • 1. Continuous Medical Education Department of Neurosurgery, HKL 14 February 2007 The Pathophysiology and Management of Hemorrhagic Stroke
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Titrate from 0.05–0.2 µg · kg -1 · min -1 Norepinephrine 2–20 µg · kg -1 · min -1 Dopamine 2–10 µg · kg -1 · min -1 Phenylephrine Volume replenishment is the first line of approach. Isotonic saline or colloids can be used and monitored with central venous pressure or pulmonary artery wedge pressure. If hypotension persists after correction of volume deficit, continuous infusions of pressors should be considered, particularly for low systolic blood pressure such as <90 mm Hg. Low blood pressure 4. If ICP monitoring is available, cerebral perfusion pressure should be kept at >70 mm Hg. 3. If systolic BP is <180 mm Hg and diastolic BP <105 mm Hg, defer antihypertensive therapy. Choice of medication depends on other medical contraindications (eg, avoid labetalol in patients with asthma). 2. If systolic BP is 180 to 230 mm Hg, diastolic BP 105 to 140 mm Hg, or mean arterial BP 130 mm Hg on 2 readings 20 minutes apart, institute intravenous labetalol, esmolol, enalapril, or other smaller doses of easily titratable intravenous medications such as diltiazem, lisinopril, or verapamil. 1. If systolic BP is >230 mm Hg or diastolic BP >140 mm Hg on 2 readings 5 minutes apart, institute nitroprusside. 0.625–1.2 mg Q 6 h as needed Enalapril 10–20 mg Q 4–6 h Hydralazine 0.5–10 µg · kg -1 · min -1 Nitroprusside 500 µg/kg as a load; maintenance use, 50–200 µg · kg -1 · min -1 Esmolol 5–100 mg/h by intermittent bolus doses of 10–40 mg or continuous drip (2–8 mg/min) Labetalol Elevated blood pressure
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52. Summary of Guidelines for Removal of ICH American Heart Association : Guidelines for the Management of Spontaneous Intracerebral Hemorrhage, 1998 Best therapy unclear Young patients with a moderate or large lobar hemorrhage who are clinically deteriorating (levels of evidence II through V, grade B recommendation). 3. ICH associated with a structural lesion such as an aneurysm, arteriovenous malformation, or cavernous angioma may be removed if the patient has a chance for a good outcome and the structural vascular lesion is surgically accessible (levels of evidence III through V, grade C recommendation). 2. Patients with cerebellar hemorrhage >3 cm who are neurologically deteriorating or who have brain stem compression and hydrocephalus from ventricular obstruction should have surgical removal of the hemorrhage as soon as possible (levels of evidence III through V, grade C recommendation). 1. Surgical candidates Patients with a GCS score  4 (levels of evidence II through V, grade B recommendation). However, patients with a GCS score  4 who have a cerebellar hemorrhage with brain stem compression may still be candidates for lifesaving surgery in certain clinical situations. 2. Patients with small hemorrhages (<10 cm 3 ) or minimal neurological deficits (levels of evidence II through V, grade B recommendation). 1. Nonsurgical candidates
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70. ICH Evaluation and Treatment
  • 71.
  • 72.
  • 73.
  • 74. Supported by Levels III through V evidence Grade C Supported by Level II evidence Grade B Supported by Level I evidence Grade A Strength of recommendation Data from anecdotal case series Level V Data from nonrandomized cohort studies using historical controls Level IV Data from nonrandomized concurrent cohort studies Level III Data from randomized trials with high false-positive (  ) or high false-negative (ß) errors Level II Data from randomized trials with low false-positive (  ) and low false-negative (ß) errors Level I Level of evidence